TVTX logo

Travere Therapeutics (TVTX) Operating Margin

Annual Operating Margin

-259.40%
+32.77%+11.22%

December 31, 2023


Summary


Performance

TVTX Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXprofitabilitymetrics:

Quarterly Operating Margin

-89.07%
+34.83%+28.11%

September 30, 2024


Summary


Performance

TVTX Quarterly Operating Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTVTXprofitabilitymetrics:

Operating Margin Formula

Operating Profit Margin =  Operating Profit
Revenue
✕ 100%

TVTX Operating Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+11.2%+51.5%
3 y3 years-582.5%+69.9%
5 y5 years-520.3%+69.9%

TVTX Operating Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-71.5%+11.2%-131.4%+73.5%
5 y5-year-582.5%+11.2%-131.4%+73.5%
alltimeall time-1204.8%+11.2%-131.4%+99.9%

Travere Therapeutics Operating Margin History

DateAnnualQuarterly
Sep 2024
-
-89.07%(-28.1%)
Jun 2024
-
-123.90%(-63.1%)
Mar 2024
-
-335.91%(+82.7%)
Dec 2023
-259.40%(-11.2%)
-183.85%(-26.3%)
Sep 2023
-
-249.59%(-22.7%)
Jun 2023
-
-322.87%(+2.4%)
Mar 2023
-
-315.23%(+6.7%)
Dec 2022
-292.17%(+93.1%)
-295.52%(+0.4%)
Sep 2022
-
-294.23%(+163.2%)
Jun 2022
-
-111.77%(-5.0%)
Mar 2022
-
-117.66%(-141.5%)
Dec 2021
-151.27%(+298.0%)
283.32%(-1183.0%)
Sep 2021
-
-26.16%(-57.7%)
Jun 2021
-
-61.90%(-24.7%)
Mar 2021
-
-82.19%(+66.2%)
Dec 2020
-38.01%(-33.2%)
-49.45%(+76.2%)
Sep 2020
-
-28.06%(-27.8%)
Jun 2020
-
-38.87%(+9.3%)
Mar 2020
-
-35.56%(-12.3%)
Dec 2019
-56.92%
-40.56%(-7.4%)
Sep 2019
-
-43.80%(-41.0%)
DateAnnualQuarterly
Jun 2019
-
-74.21%(+6.5%)
Mar 2019
-
-69.65%(+90.2%)
Dec 2018
-41.82%(+110.4%)
-36.61%(-21.5%)
Sep 2018
-
-46.63%(-0.6%)
Jun 2018
-
-46.93%(+26.3%)
Mar 2018
-
-37.17%(+168.0%)
Dec 2017
-19.88%(-31.8%)
-13.87%(+10.9%)
Sep 2017
-
-12.51%(-52.9%)
Jun 2017
-
-26.58%(-19.2%)
Mar 2017
-
-32.91%(+20.8%)
Dec 2016
-29.15%(-9.7%)
-27.24%(-37.2%)
Sep 2016
-
-43.36%(+68.1%)
Jun 2016
-
-25.79%(+34.9%)
Mar 2016
-
-19.12%(-31.1%)
Dec 2015
-32.29%(-88.6%)
-27.75%(-12.5%)
Sep 2015
-
-31.71%(+11.9%)
Jun 2015
-
-28.35%(-39.2%)
Mar 2015
-
-46.65%(-64.9%)
Dec 2014
-282.98%
-132.74%(-49.3%)
Sep 2014
-
-261.91%(-12.5%)
Jun 2014
-
-299.23%(-99.6%)
Mar 2014
-
-79.07 K%

FAQ

  • What is Travere Therapeutics annual operating profit margin?
  • What is the all time high annual operating margin for Travere Therapeutics?
  • What is Travere Therapeutics annual operating margin year-on-year change?
  • What is Travere Therapeutics quarterly operating profit margin?
  • What is the all time high quarterly operating margin for Travere Therapeutics?
  • What is Travere Therapeutics quarterly operating margin year-on-year change?

What is Travere Therapeutics annual operating profit margin?

The current annual operating margin of TVTX is -259.40%

What is the all time high annual operating margin for Travere Therapeutics?

Travere Therapeutics all-time high annual operating profit margin is -19.88%

What is Travere Therapeutics annual operating margin year-on-year change?

Over the past year, TVTX annual operating profit margin has changed by +32.77% (+11.22%)

What is Travere Therapeutics quarterly operating profit margin?

The current quarterly operating margin of TVTX is -89.07%

What is the all time high quarterly operating margin for Travere Therapeutics?

Travere Therapeutics all-time high quarterly operating profit margin is 283.32%

What is Travere Therapeutics quarterly operating margin year-on-year change?

Over the past year, TVTX quarterly operating profit margin has changed by +94.78% (+51.55%)